RxDoctor Payments Data

Neal Dharmadhikari, MD

Gastroenterology · Atlanta, GANPI 1528597689

Payments from drug & device makers

What this record shows

This record is dominated by grants: $25,000 of the $35,927 with a category attached, or 69.6%. Boston Scientific accounts for 89.7% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2024 at $16,064 and has fallen 77.1% since, to $3,680 in 2025. Among gastroenterology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,927in general payments, 2019–2025

Across 127 payments — averaging $282.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$32K
  • Olympus Corporation Of The Americas$647
  • Apollo Endosurgery US Inc$596
  • Conmed Corporation$543
  • AbbVie$347
  • Omega Medical Imaging, LLC$297
  • plus $1K from 19 others

What the payments were for

  • Grants$25,00070%
  • Travel & lodging$5,49215%
  • Food & beverage$5,43515%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,927 in reported general payments places this provider in the 95th percentile of 492 gastroenterology providers in Georgia.

See all gastroenterology providers in Georgia

Medicare billing

Part B allowed, 2024
$12,544
Medicare patients
62
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate15$508
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl31$419
Omeprazole25$269
Pantoprazole Sodium12$124
Ciprofloxacin Hcl16$69

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →